ATE196775T1 - Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon - Google Patents

Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon

Info

Publication number
ATE196775T1
ATE196775T1 AT94919120T AT94919120T ATE196775T1 AT E196775 T1 ATE196775 T1 AT E196775T1 AT 94919120 T AT94919120 T AT 94919120T AT 94919120 T AT94919120 T AT 94919120T AT E196775 T1 ATE196775 T1 AT E196775T1
Authority
AT
Austria
Prior art keywords
ligands
agonists
antagonists
mammal
purified
Prior art date
Application number
AT94919120T
Other languages
English (en)
Inventor
Charles H Hannum
Frank D Lee
Daniel Birnbaum
Janice A Culpepper
Original Assignee
Schering Corp
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27568243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE196775(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp, Inst Nat Sante Rech Med filed Critical Schering Corp
Application granted granted Critical
Publication of ATE196775T1 publication Critical patent/ATE196775T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94919120T 1993-05-19 1994-05-18 Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon ATE196775T1 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US6523193A 1993-05-19 1993-05-19
US8926393A 1993-07-07 1993-07-07
US9254993A 1993-07-16 1993-07-16
US10634093A 1993-08-13 1993-08-13
US11239193A 1993-08-24 1993-08-24
US15511193A 1993-11-19 1993-11-19
US16241393A 1993-12-03 1993-12-03
PCT/US1994/005150 WO1994026891A2 (en) 1993-05-19 1994-05-18 Purified mammalian flt3 ligands and agonists and antagonists thereof

Publications (1)

Publication Number Publication Date
ATE196775T1 true ATE196775T1 (de) 2000-10-15

Family

ID=27568243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919120T ATE196775T1 (de) 1993-05-19 1994-05-18 Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon

Country Status (7)

Country Link
EP (2) EP0699236B2 (de)
JP (1) JPH09501822A (de)
AT (1) ATE196775T1 (de)
AU (1) AU7017494A (de)
DE (1) DE69426076T3 (de)
ES (1) ES2150495T5 (de)
WO (1) WO1994026891A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ307995A3 (en) * 1993-05-24 1996-10-16 Immunex Corp Ligands for flt3 receptors
US7045128B2 (en) 1993-05-24 2006-05-16 Immunex Corporation Antibodies against flt3-ligand
US7294331B2 (en) 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US7361330B2 (en) 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US6660257B1 (en) 1996-10-25 2003-12-09 Pharmacia Corporation Circular permuteins of flt3 ligand
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US7112409B2 (en) 1999-01-29 2006-09-26 Center For Molecular Medicine And Immunology Method of determining cytokine dosage for myelosuppressive state
US6649352B1 (en) 1999-01-29 2003-11-18 Center For Molecular Medicine And Immunology Method of evaluating myelosuppressive state
US20140243239A1 (en) * 2011-10-12 2014-08-28 University Of North Carolina At Chapel Hill Multiplexed kinase inhibitor beads and uses thereof
JP2022512540A (ja) 2018-08-29 2022-02-07 シャタック ラボ，インコーポレイテッド Ｆｌｔ３ｌ系キメラタンパク質
EP3902836B1 (de) 2018-12-18 2026-03-25 Boehringer Ingelheim IO Canada Inc. Flt3-agonistische antikörper und ihre verwendungen
CN113454231A (zh) * 2018-12-21 2021-09-28 渥太华医院研究所 修饰的正痘病毒载体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE160877T1 (de) * 1988-08-12 1997-12-15 Ligand Pharm Inc Polypeptid-induzierte monoklonale rezeptoren gegen proteinliganden
HUT62011A (en) * 1989-10-16 1993-03-29 Amgen Inc Process for producing factors influencing the functioning of stem cells
US5185438A (en) * 1991-04-02 1993-02-09 The Trustees Of Princeton University Nucleic acids encoding hencatoporetic stem cell receptor flk-2
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors

Also Published As

Publication number Publication date
EP0992584A3 (de) 2000-06-07
WO1994026891A3 (en) 1995-01-19
EP0992584A2 (de) 2000-04-12
JPH09501822A (ja) 1997-02-25
WO1994026891A2 (en) 1994-11-24
DE69426076T3 (de) 2007-01-18
AU7017494A (en) 1994-12-12
EP0699236B2 (de) 2006-06-14
EP0699236B1 (de) 2000-10-04
ES2150495T3 (es) 2000-12-01
EP0699236A1 (de) 1996-03-06
DE69426076T2 (de) 2001-05-10
ES2150495T5 (es) 2007-02-16
DE69426076D1 (de) 2000-11-09

Similar Documents

Publication Publication Date Title
DK0758383T3 (da) Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof
DE69426076D1 (de) Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon
DE69535641D1 (de) Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
DK0673420T3 (da) Mammale receptorer for interleukin 10 (IL-10)
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ATE362982T1 (de) ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
PT662827E (pt) Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos
DE69841273D1 (de) Verfahren zur identifikation von bindestellendomänen, die ihre epitopbindefähigkeit beibehalten
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
NZ236511A (en) Polypeptides containing sequences from residues 61 to 82 or 104 to 129 of human il-4 or subsequences thereof; antibodies and pharmaceutical compositions
EP0686161A4 (de) Alpha untereinheit des humanen beta-2 integrins
DE69837268D1 (de) Neue moleküle aus der familie der tango-77-ähnlichen proteine und ihre verewendungen.
ATE335818T1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
ATE353964T1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
DK0973794T3 (da) Netrinreceptorer
Chen et al. Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE179712T1 (de) Analoge für spezifische oligosaccharid-protein- wechselwirkungen und ihre verwendungen
NO882380D0 (no) Fibfonektin-bindende protein, samt fremstilling derav.
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
DE3888031D1 (de) Homocyclostatin und Cyclostatin enthaltende Polypeptide als Antihypertensiva.
ATE78513T1 (de) Immunoglobulin-a-rezeptor-protein (arp), sowie dessen klonierung und expression.